Mouse strain determines the outcome of wound healing after myocardial infarction

Cardiovascular Research

Volumn 84, Issue 2, 2009, Pages 273-282

  Van Den Borne, Susanne W M ^a   Van De Schans, Veerle A M ^a   Strzelecka, Agnieszka E ^a   Vervoort Peters, Helena T M ^a   Lijnen, Peter M ^a   Cleutjens, Jack P M ^a   Smits, Jos F M ^a   Daemen, Mat J A P ^a   Janssen, Ben J A ^a   Blankesteijn, W Matthijs ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Genetic background; Heart failure; Infarct rupture; Inflammatory cells; Myocardial infarction

Indexed keywords

HYDRALAZINE; MATRIX METALLOPROTEINASE; MESSENGER RNA; METOPROLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; HEART DILATATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTILITY; HEART SIZE; HEART VENTRICLE PRESSURE; HISTOLOGY; HYPERTENSION; INCIDENCE; INFLAMMATORY CELL; MALE; MOUSE; MOUSE STRAIN; MYOFIBROBLAST; NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SWISS WEBSTER MOUSE; SYSTOLIC BLOOD PRESSURE; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART RUPTURE, POST-INFARCTION; INFLAMMATION; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIES SPECIFICITY; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; WOUND HEALING;

EID: 71549122284     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp207     Document Type: Article

References (28)

1. van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Smits JF, Daemen MJ et al. Increased matrix metalloproteinase-8 and-9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 2008;18:37-43.
2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172.
3. Linder CC. Genetic variables that influence phenotype. ILAR J 2006;47: 132-140.
4. Hoover-Plow J, Shchurin A, Hart E, Sha J, Hill AE, Singer JB et al. Genetic background determines response to hemostasis and thrombosis. BMC Blood Disord 2006;6:6-18.
5. Majid A, He YY, Gidday JM, Kaplan SS, Gonzales ER, Park TS et al. Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke 2000;31:2707-2714.
6. Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ. Mouse model of post-infarct ventricular rupture: time course, strain-and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 2005;65:469-477.
7. Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 1999;41:586-593.
8. De Celle T, Cleutjens JP, Blankesteijn WM, Debets JJ, Smits JF, Janssen BJ. Long-term structural and functional consequences of cardiac ischaemia-reperfusion injury in vivo in mice. Exp Physiol 2004;89:605-615.
9. Creemers E, Cleutjens J, Smits J, Heymans S, Moons L, Collen D et al. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 2000;156:1865-1873.
10. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 1995;27:1281-1292.
11. van de Schans VA, van den Borne SW, Strzelecka AE, Janssen BJ, van der Velden JL, Langen RC et al. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy. Hypertension 2007;49:473-480.
12. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, Ming Z et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007;43:535-544.
13. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-1142.
14. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 2003;285:H1229-H1235.
15. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 2005; 115:599-609.
16. Tao ZY, Cavasin MA, Yang F, Liu YH, Yang XP. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci 2004;74: 1561-1572.
17. Wehrens XH, Doevendans PA. Cardiac rupture complicating myocardial infarction. Int J Cardiol 2004;95:285-292.
18. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL et al. Effectsofcandesartaninpatients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767-771. (Pubitemid 37093916)
19. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345: 1667-1675.
20. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385-1390.
21. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 1972;135:719-734.
22. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200:500-503.
23. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
24. Willems IE, Havenith MG, De Mey JG, Daemen MJ. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 1994;145:868-875.
25. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 1996;19: 177-181.
26. Du XJ. Gender modulates cardiac phenotype development in genetically modified mice. Cardiovasc Res 2004;63:510-519.
27. Cavasin MA, Tao Z, Menon S, Yang XP. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 2004;75:2181-2192.
28. Bujak M, Kweon HJ, Chatila K, Li N, Taffet G, Frangogiannis NG. Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol 2008;51:1384-1392.